Skip to main content
logo
Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
253.29
-1.52 (-0.60%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Revenue

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
YORVIPATH Revenue
778.78M477.41M28.73M
SKYTROFA Revenue
203.29M206.16M197.00M
Commercial Products Revenue
989.65M683.57M225.73M
Services and Clinical Supply Revenue
20.88M18.01M15.57M
Licenses Revenue
6.53M5.63M122.34M
Milestones Revenue
-12.92M-
Revenue (Other)
-748.81M-477.41M-28.73M
Revenue (Total)
1.05B720.13M363.64M

Revenue by Geography

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
United States Revenue
838.80M546.39M233.12M
Europe Revenue
157.71M120.95M123.34M
Rest of World Revenue
50.50M52.80M7.19M
Revenue (Total)
1.05B720.13M363.64M

Key Performance Indicators

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Number of Unique U.S. Patient Enrollments - YORVIPATH
5.30K908.00
Number of Unique Prescribing Healthcare Providers - YORVIPATH
2.40K539.00